Interesting trial this week pitting an elaborate nurse led group against suboptimal usual care.  Suboptimal usual care lost pretty badly, but what to make of this?  And does it support the rheumatologist side of the treat to target controversy?  Listen to find out and be sure to follow on @EBRheum if you have your own thoughts!